NEWS RELEASE
CONTACT COMPANY
MICHAEL HROMADIK
SOLTA MEDICAL, INC.
(510) 780-4694
mhromadik@solta.com
MEDIA RELATIONS
CHRIS LALLI
COHN & WOLFE
(415) 365-8540
Chris.lalli@cohnwolfe.com
mm
SOLTA MEDICAL LAUNCHES NEW FRAXEL RE:STORE
®
DUAL LASER SYSTEM
Breakthrough Skin Resurfacing Technology for Faster Clearance of Pigment and Advanced Off-Face Treatments
HAYWARD, Calif., August 26, 2009 – Solta Medical, Inc. (Nasdaq: SLTM) today announced the launch of its new Fraxel
re:store® Dual system, providing superior results for large body areas during a single treatment. Prior to the non-ablative Fraxel
re:store Dual system, laser skin resurfacing procedures were largely limited to the face. The Fraxel re:store Dual takes the
industry leading fractional laser technology to the next level by adding a novel 1927 nm wavelength, the first ever application of
a Thulium laser in the aesthetics market, optimized for treatment of pigmentation and other superficial skin conditions.
“The expanded versatility of the Fraxel re:store Dual system, with the addition of the new 1927 nm wavelength, increases the
areas of the body that I can treat and provides a superior treatment for pigmentation and actinic keratoses associated with
photodamage,” said Roy Geronemus, MD, director of the Laser & Skin Surgery Center of New York.
Vic Narurkar, MD, founder of the Bay Area Laser Institute added, “The Fraxel re:store Dual allows me to offer patients the
safety, comfort and minimal downtime of a non-ablative treatment, and achieve results superior to superficial fractional CO2
treatments.”
The product launch comes on the heels of Solta’s announcement last week of the new Thermage CPT™ system for skin
tightening and body contouring. Together, these cutting edge developments further secure Solta’s leadership position in the
aesthetic energy device industry.
“Solta Medical is committed to developing innovative, safe, and effective anti-aging solutions that enhance and expand the
practice of medical aesthetics for our physician customers,” said Stephen J. Fanning, Chairman of the Board, President and CEO
of Solta Medical, Inc. “With the launch of a major new product from each of our industry-leading Thermage and Fraxel brands,
Solta takes another step forward in fulfilling our mission to be the leader in developing transformational aesthetic treatments,
building world class brands and providing long-term value for our stakeholders.”
Fraxel re:store Dual system features and benefits include:
 Dual fiber laser technology in one system providing the most effective non-ablative skin resurfacing treatment
 Accelerated clearance of unwanted pigmentation via ground-breaking use of a Thulium laser
 Ease of operation and improved patient comfort with focal cooling built directly into the hand piece
 Treatment of larger and multiple body areas in a single session due to enhanced comfort profile with 1927 nm
wavelength
 Increased procedure speed by 25% with newly improved scanner design
NEWS RELEASE
Solta Medical is proud to be celebrating the launch of this new product along with the Thermage CPT system through the
illumiNATION tour. Beginning in September and continuing through November, the illumiNATION tour will bring the new
Fraxel re:store Dual system and Thermage CPT system to physicians in over 20 cities across the U.S. and 11 cities in Europe on
board a state-of-the-art, custom-outfitted Airstream®. Come join the excitement by visiting www.illuminationtour.com for more
information and to register for a tour stop.
ABOUT SOLTA MEDICAL, INC.
Solta Medical is a global leader in the medical aesthetics market providing innovative, safe, and effective anti-aging solutions
for patients that enhance and expand the practice of medical aesthetics for physicians. The company offers products to address
aging skin under the industry's two premier brands: Thermage® and Fraxel®. Thermage is an innovative, non- invasive
radiofrequency procedure for tightening and contouring skin. As the leader in fractional laser technology, Fraxel delivers
minimally invasive clinical solutions to resurface aging and sun damaged skin. Since 2002, approximately one million
Thermage and Fraxel procedures have been performed in nearly 80 countries. Thermage and Fraxel are the perfect complement
for any aesthetic practice. For more information about Solta Medical, call 1-877-782-2286 or log on to http://www.Solta.com.
The Fraxel re:store 1550 nm laser is FDA cleared for the treatment of pigmented lesions, acne scars, melasma, mild to
moderate periorbital rhytids, surgical scars and actinic keratosis. The Fraxel re:store 1927 nm wavelength is pending FDA
510(k) clearance.
© 2009 Solta Medical, Inc. All rights reserved. Thermage, Fraxel, Fraxel re:store and Solta Medical are trademarks or
registered trademarks of Solta Medical, Inc. or its subsidiaries.